Literature DB >> 16025274

In vitro verification of the correlation of in vivo 99mTc-(V)DMSA uptake with cellular proliferation rate.

Vassilios Papantoniou, Spyridon Tsiouris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16025274     DOI： 10.1007/s00259-005-1860-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  8 in total

1.  Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines.

Authors:  Delphine Denoyer; Nathalie Perek; Nathalie Le Jeune; Jérôme Cornillon; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-23       Impact factor: 9.236

2.  99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.

Authors:  V Papantoniou; J Christodoulidou; E Papadaki; V Valotassiou; A Stipsanelli; A Louvrou; D Lazaris; M Sotiropoulou; G Pampouras; A Keramopoulos; S Michalas; C Zerva
Journal:  Eur J Nucl Med       Date:  2001-07

3.  Recurrent bilateral mammary fibromatosis (desmoid tumor) imaged with technetium-99m pentavalent dimercaptosuccinic acid [99mTc-(V)DMSA] scintimammography.

Authors:  Vassilios Papantoniou; John Koutsikos; Maria Sotiropoulou; Eleni Feida; Spyridon Tsiouris
Journal:  Gynecol Oncol       Date:  2005-06       Impact factor: 5.482

4.  Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.

Authors:  Abeer M Shaaban; John P Sloane; Christopher R West; Christopher S Foster
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

5.  Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines.

Authors:  Delphine Denoyer; Nathalie Perek; Nathalie Le Jeune; Delphine Frere; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-14       Impact factor: 9.236

6.  Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report.

Authors:  Vassilas Papantoniou; John Koutsikos; Maria Sotiropoulou; Ekaterini Mainta; Dimitrias Lazaris; Spyridon Tsiouris; Cherry Zerva
Journal:  Jpn J Clin Oncol       Date:  2004-07       Impact factor: 3.019

7.  Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.

Authors:  Vassilios J Papantoniou; Michael A Souvatzoglou; Varvara J Valotassiou; Androniki N Louvrou; Constantina Ambela; John Koutsikos; Dimitrios Lazaris; Julie K Christodoulidou; Maria G Sotiropoulou; Maria J Melissinou; Aris Perperoglou; Spyridon Tsiouris; Cherry J Zerva
Journal:  Breast Cancer Res       Date:  2003-12-11       Impact factor: 6.466

8.  Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.

Authors:  Vassilios Papantoniou; Spyridon Tsiouris; Ekaterini Mainta; Varvara Valotassiou; Michael Souvatzoglou; Maria Sotiropoulou; Lydia Nakopoulou; Dimitrios Lazaris; Androniki Louvrou; Maria Melissinou; Artemis Tzannetaki; Ioannis Pirmettis; John Koutsikos; Cherry Zerva
Journal:  Breast Cancer Res       Date:  2004-11-08       Impact factor: 6.466
  8 in total
  2 in total

1.  Influence of Pi3-K and PKC activity on 99mTc-(V)-DMSA uptake: correlation with tumour aggressiveness in an in vitro malignant glioblastoma cell line model.

Authors:  Nathalie Le Jeune; Nathalie Perek; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-09       Impact factor: 9.236

2.  Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response.

Authors:  Spyridon Tsiouris; Ioannis Pirmettis; Theodoros Chatzipanagiotou; Nikolaos Ptohis; Vassilios Papantoniou
Journal:  J Neurooncol       Date:  2007-06-07       Impact factor: 4.130
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.